C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel

There are limited absolute biomarkers for determining the prognosis before first- and second-line palliative chemotherapy in unresectable pancreatic cancer (urPC) patients. To find the best prognostic inflammatory marker, we investigated relationships between overall survival (OS) and six inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirakawa, Tsuyoshi, Makiyama, Akitaka, Shimokawa, Mototsugu, Otsuka, Taiga, Shinohara, Yudai, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Otsu, Satoshi, Komori, Azusa, Arima, Shiho, Fukahori, Masaru, Taguchi, Hiroki, Honda, Takuya, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Mizuta, Toshihiko, Mitsugi, Kenji, Akashi, Koichi, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232544/
https://www.ncbi.nlm.nih.gov/pubmed/37258608
http://dx.doi.org/10.1038/s41598-023-34962-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232544/
https://www.ncbi.nlm.nih.gov/pubmed/37258608
http://dx.doi.org/10.1038/s41598-023-34962-7

Ejemplares similares